Form 4: OraSure Technologies CEO Receives Restricted Stock Award, Sells Shares for Tax Obligations

Carrie Eglinton Manner, President & CEO of OraSure Technologies, received a restricted stock award and sold shares to cover tax liabilities.

Summary

• Carrie Eglinton Manner, the President and CEO of OraSure Technologies, received a grant of 260,688 shares of restricted stock on March 1, 2024.
• These shares vest in three equal annual installments starting March 1, 2025, contingent upon continuous service.
• On the same day, Ms. Manner sold 29,647 shares of common stock at a price of $7.1925 per share to cover the tax liability associated with the vesting of restricted shares.
• Following these transactions, Ms. Manner beneficially owns 1,582,657 shares of OraSure Technologies common stock.

Sentiment

Score: 6

Explanation: The document is neutral in tone, simply reporting transactions. The stock grant is a positive sign of alignment, but the sale to cover taxes is a minor negative.

Positives

• The grant of restricted stock aligns the CEO's interests with those of the shareholders, incentivizing long-term performance.

Negatives

• The sale of shares to cover tax liabilities, while common, could be perceived negatively by some investors if they believe the CEO is reducing their stake in the company.

Risks

• The vesting of the restricted stock is contingent upon the CEO's continuous service, creating a potential risk if she were to leave the company before the vesting dates.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedule of the restricted stock award suggests a commitment to the company for at least three years.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The grant of restricted stock is a common practice to incentivize executives.

Comparison to Industry Standards

• Stock grants are a common form of compensation for executives in publicly traded companies, particularly in the technology and healthcare sectors.
• Companies like Abbott Laboratories and Becton Dickinson also use stock grants as part of their executive compensation packages.
• The vesting schedule of three years is fairly standard for restricted stock awards.

Stakeholder Impact

• Shareholders may view the stock grant as a positive incentive for the CEO.
• Employees may see the CEO's continued investment in the company as a sign of confidence.

Key Dates